1130514

Christopher van Dyck, M.D. — FEI 3017149376

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 10, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Haven, CT (United States)

Additional Details

Clinical Investigator (CI)